Spain Embolization Particle Procedures Count by Segments and Forecast to 2030
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Spain Embolization Particle Procedures Market Report Overview
The total number of Embolization Particle procedures conducted in Spain was 2,813 in 2022. In procedures using embolization particles, a small catheter is placed inside a blood vessel to reach the area that is bleeding, and the catheter is navigated under image guidance to the farthest point with other different embolic materials that help block the bleeding vessels.
The Spain Embolization Particle procedures market research report is a comprehensive databook report, covering key procedures data on the Spain Embolization Particle Procedures. The report also provides procedure volumes within segments.
Market Size (2022) | 2,813 Procedures |
Forecast Period | 2023-2030 |
Historical Period | 2015-2022 |
Key Segments | Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Benign prostatic hyperplasia, Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Embolization Particle Procedures to treat Uterine Fibroids, Embolization Particle Procedures to treat Renal Cell Carcinoma, Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, and Embolization Particle Procedures to treat Arteriovenous Malformations |
Spain Embolization Particle Procedures Market Segments
The key segments in the Spain Embolization Particle procedures market are Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Benign prostatic hyperplasia, Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Embolization Particle Procedures to treat Uterine Fibroids, Embolization Particle Procedures to treat Renal Cell Carcinoma, Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, and Embolization Particle Procedures to treat Arteriovenous Malformations. In 2022, Embolization Particle Procedures to treat Benign prostatic hyperplasia led the Spain Embolization Particle procedures market.
Embolization Particle Procedures to treat Benign Prostatic Hyperplasia: Lower urinary tract infections caused by Benign Prostatic Hyperplasia is treated by prostatic artery embolization (PAE), an embolization procedure. A tiny hole is made in the groin to execute prostatic artery embolization. Through the artery, a catheter is inserted and pointed at the prostate. Once the catheter is in the prostate’s blood vessel, a little amount of material is injected to limit blood flow by plugging the artery. Embolization Particle Procedures to treat benign prostatic hyperplasia (BPH) can be further segmented into procedures using microspheres and procedures using polyvinyl alcohol (PVA) particles.
Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease: Numerous cancer forms frequently metastasize to the liver. The colorectal cancer, along with breast, esophageal, stomach, pancreatic, lung, kidney, and melanoma skin cancers, is the cancer that spreads to the liver most frequently. In Embolization procedure embolization substances are directly injected into the affected area to block or reduce the blood flow to the tumor. Embolization Particle Procedures to treat other tumors with Metastatic Liver Disease can be further segmented into Procedures using Drug-Eluting Beads, Procedures using Microspheres, Procedures using Polyvinyl Alcohol (PVA) Particles and Procedures using Radioembolization Particles.
Embolization Particle Procedures to treat Hepatocellular Carcinoma: Hepatocellular carcinoma is the most common form of liver cancer begins in cells called hepatocytes. In embolization particle procedure, by directly injecting drugs into the hepatic artery, blood flow can be restricted to the tumor. It contains two blood supplies: the portal vein feeds most healthy liver cells, whereas the hepatic artery feeds the majority of cancerous liver cells. Embolization Particle Procedures to treat Hepatocellular Carcinoma can be further segmented into Procedures using Drug-Eluting Beads, Procedures using Microspheres, Procedures using Polyvinyl Alcohol (PVA) Particles and Procedures using Radioembolization Particles.
Spain Embolization Particle Procedures Market Analysis, by Segments, 2022 (%)
For more insights into the Spain Embolization Particle procedures market segments, download a free report sample
Segments Covered in the Report
Spain Embolization Particle Procedures Segments Outlook (Number of Procedures, 2015-2030)
- Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease
- Procedures using Drug-Eluting Beads
- Procedures using Microspheres
- Procedures using Radioembolization Particles
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Embolization Particle Procedures to treat Hepatocellular Carcinoma
- Procedures using Drug-Eluting Beads
- Procedures using Radioembolization Particles
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Embolization Particle Procedures to treat Benign prostatic hyperplasia
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease
- Procedures using Drug-Eluting Beads
- Procedures using Radioembolization Particles
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Embolization Particle Procedures to treat Uterine Fibroids
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Embolization Particle Procedures to treat Renal Cell Carcinoma
- Procedures using Drug-Eluting Beads
- Procedures using Microspheres
- Procedures using Radioembolization Particles
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma
- Procedures using Drug-Eluting Beads
- Procedures using Radioembolization Particles
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease
- Procedures using Drug-Eluting Beads
- Procedures using Microspheres
- Procedures using Radioembolization Particles
- Procedures using PolyVinyl Alcohol (PVA) Particles
- Embolization Particle Procedures to treat Arteriovenous Malformations
- Procedures using Microspheres
- Procedures using PolyVinyl Alcohol (PVA) Particles
Scope
Spain Embolization Particle Procedures is segmented as follows –
• Embolization Particle Procedures to treat Arteriovenous Malformations
• Embolization Particle Procedures to treat Benign prostatic hyperplasia
• Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease
• Embolization Particle Procedures to treat Hepatocellular Carcinoma
• Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma
• Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease
• Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease
• Embolization Particle Procedures to treat Renal Cell Carcinoma
• Embolization Particle Procedures to treat Uterine Fibroids
Reasons to Buy
The Spain Embolization Particle Procedures report helps you to develop –
- Business strategies by identifying the key segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Investment strategies by identifying the key segments expected to register strong growth in the near future.
Table of Contents
Table
Figures
Frequently asked questions
-
What was the Spain Embolization Particle procedures market size in 2022?
The total number of Embolization Particle procedures conducted in Spain was 2,813 in 2022.
-
What are the key segments in the Spain Embolization Particle procedures market?
The key segments in the Spain Embolization Particle procedures market are Embolization Particle Procedures to treat Colorectal Cancer with Metastatic Liver Disease, Embolization Particle Procedures to treat Hepatocellular Carcinoma, Embolization Particle Procedures to treat Benign prostatic hyperplasia, Embolization Particle Procedures to treat Other tumors with Metastatic Liver Disease, Embolization Particle Procedures to treat Uterine Fibroids, Embolization Particle Procedures to treat Renal Cell Carcinoma, Embolization Particle Procedures to treat Intrahepatic cholangiocarcinoma, Embolization Particle Procedures to treat Neuroendocrine tumors with Metastatic Liver Disease, and Embolization Particle Procedures to treat Arteriovenous Malformations.
-
Which was the leading segment in the Spain Embolization Particle procedures market in 2022?
In 2022, Embolization Particle Procedures to treat Benign prostatic hyperplasia was the leading segment in the Spain Embolization Particle procedures market
-
How is the Embolization Particle Procedure conducted?
The Embolization Particle Procedure is conducted by placing a small catheter inside a blood vessel to reach the area that is bleeding. The catheter is then navigated under image guidance to the farthest point with other different embolic materials that helps in blocking the bleeding vessels.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.